Leerink Partners analyst Michael Cherny raised the price target on Hims and Hers (NYSE: HIMS) to $43.00 (from $42.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

BTIG Reiterates Buy Rating on Hims and Hers (HIMS), PT $85August 5, 2025 9:32 AM After-hours movers: Palantir, Hims & Hers, Vertex Pharma and moreAugust 4, 2025 4:36 PM Form 4 Hims & Hers Health, Inc. For: Jul 31 Filed by: Chi MichaelAugust 4, 2025 4:21 PM Form 10-Q Hims & Hers Health, Inc. For: Jun 30August 4, 2025 4:19 PM Form 8-K Hims & Hers Health, Inc. For: Aug 04August 4, 2025 4:13 PM Hims & Hers Health (HIMS) Tops Q2 EPS by 2c, Revenue Misses, Offers GuidanceAugust 4, 2025 4:10 PM Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial ResultsAugust 4, 2025 4:05 PM Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.4 puts into quarter results August 4, 2025 5:44 AM Form 144 Hims & Hers Health, Inc. Filed by: Chi MichaelAugust 1, 2025 11:12 AM Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.6 puts into quarter results August 1, 2025 11:06 AM Eli Lilly stock rises, Novo Nordisk shares jump on potential Medicare coverageAugust 1, 2025 8:27 AM